These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4412561)

  • 21. The antiarrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol.
    Schuster DP; Lucchesi BR; Nobel NL; Mimnaugh MN; Counsell RE; Kniffen FJ
    J Pharmacol Exp Ther; 1973 Jan; 184(1):213-27. PubMed ID: 4405548
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis and antiarrhythmic activity of disubstituted phenylpyridine derivative.
    Shigyo H; Sato S; Shibuya K; Takahashi Y; Yamaguchi T; Sonoki H; Ohta T
    Chem Pharm Bull (Tokyo); 1993 Sep; 41(9):1573-82. PubMed ID: 8221971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antiarrhythmic activity of alpha-[(diarylmethoxy)methyl]-1-piperidineethanols.
    Hoefle ML; Blouin LT; Fleming RW; Hastings S; Hinkley JM; Mertz TE; Steffe TJ; Stratton CS; Werbel LM
    J Med Chem; 1991 Jan; 34(1):7-12. PubMed ID: 1992154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiarrhythmic activity of some N-alkylbispidinebenzamides.
    Ruenitz PC; Mokler CM
    J Med Chem; 1979 Sep; 22(9):1142-4. PubMed ID: 490563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experimental models for the pharmacologic study of anti-arrhythmia drugs].
    Vainsel H; Dodion L; Bernard R; Denolin H
    Acta Cardiol; 1977; Suppl 22():33-35. PubMed ID: 327735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
    Bergey JL; Sulkowski T; Much DR; Wendt RL
    Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of the effects of disopyramide and hydroquinidine in animals].
    Lisin N; Carlier J
    Arch Mal Coeur Vaiss; 1973 Oct; 66(10):1329-35. PubMed ID: 4207476
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis, stereochemistry, and antiarrhythmic activity of some 8-substituted decahydroisoquinolines.
    Mathison IW; Morgan PH
    J Med Chem; 1974 Nov; 17(11):1136-9. PubMed ID: 4416034
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.
    Schmid JR; Hanna C
    J Pharmacol Exp Ther; 1967 May; 156(2):331-8. PubMed ID: 4381702
    [No Abstract]   [Full Text] [Related]  

  • 30. Antiarrhythmic actions of BC 105.
    Ahmad M; Achari G
    Jpn J Pharmacol; 1969 Mar; 19(1):19-24. PubMed ID: 5306219
    [No Abstract]   [Full Text] [Related]  

  • 31. Antiarrhythmic effects of HOE642, a novel Na(+)-H+ exchange inhibitor, on ventricular arrhythmias in animal hearts.
    Xue YX; Aye NN; Hashimoto K
    Eur J Pharmacol; 1996 Dec; 317(2-3):309-16. PubMed ID: 8997615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system].
    Seipel L; Breithardt G; Both A
    Z Kardiol; 1975 Aug; 64(8):731-40. PubMed ID: 1163095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Proceedings: Anti-arrhythmic action of disopyramide].
    Nakamura T; Takahashi K; Niitani U; Sugiura T; Miyaji K
    Jpn Circ J; 1975 Apr; 39(4):497. PubMed ID: 1121090
    [No Abstract]   [Full Text] [Related]  

  • 34. The specificity of potassium canrenoate, a steroidal antidysrhythmic drug.
    Yeh BK; Sung PK; Lazzara R
    Clin Pharmacol Ther; 1974 Dec; 16(6):1014-22. PubMed ID: 4433469
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of BN 52256 and other mediator antagonists on ouabain-induced ventricular fibrillation in sensitized guinea-pigs and on ischemia-induced fibrillation in rats.
    Mest HJ; Rein T; Riedel A; Köpernik W; Braquet C
    Agents Actions Suppl; 1992; 37():228-34. PubMed ID: 1632298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiarrhythmic effects of droperidol.
    Bertoló L; Novaković L; Penna M
    Anesthesiology; 1972 Nov; 37(5):529-35. PubMed ID: 5079306
    [No Abstract]   [Full Text] [Related]  

  • 37. R56865, an antiarrhythmic drug with class III effects that terminates ouabain induced ventricular tachycardia in an inverse rate dependent manner.
    Vos MA; van Deursen RT; Gorgels AP; Leunissen JD; Wellens HJ
    Cardiovasc Res; 1993 Aug; 27(8):1491-7. PubMed ID: 8221803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular effects of a newer antiarrhythmic agent, disopyramide phosphate.
    Mathur PP
    Am Heart J; 1972 Dec; 84(6):764-70. PubMed ID: 4150336
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of 8-(3-diethylaminopropyl)-6,6-dimethyl-(2-phenyl-1 H-imidazo(4,5 h))isoquinoline-7,9-(6H)-dione dihydrochloride (AR-LH31) on experimental cardiac arrhythmias in dogs.
    Kerr MJ; Harron DW; Wilson R; Shanks RG
    Arzneimittelforschung; 1985; 35(1A):197-200. PubMed ID: 3838674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
    Bianchi C; Sanna GP; Turba C
    Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.